Skip to content

Identification of Regional Epidemiological Characteristics and Key Prognostic Factors of Colorectal Cancer in Xinjiang and Shandong

Identification of Regional Epidemiological Characteristics and Key Prognostic Factors of Colorectal Cancer in Xinjiang and Shandong: A Multicenter, Retrospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07526090
Enrollment
500
Registered
2026-04-13
Start date
2016-01-01
Completion date
2020-12-31
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

Colorectal Cancer, Epidemiology, Prognostic Factors, Survival, Retrospective, Multicenter, Xinjiang, Shandong

Brief summary

This is a multicenter, retrospective, cross-sectional observational study aiming to investigate the 5-year overall survival (OS) rate of colorectal cancer (CRC) patients in Xinjiang and Shandong provinces of China. A total of no less than 500 pathologically confirmed CRC patients from 7 medical centers during January 1, 2016 to December 31, 2020 will be enrolled. We will collect and analyze the demographic characteristics, lifestyle, clinical pathological features, treatment patterns and survival prognosis data of patients, explore the regional differences of CRC and its key prognostic factors, and construct a CRC prognostic prediction model. The results will provide theoretical guidance for clinical practice and the formulation of public health policies.

Detailed description

Colorectal cancer is one of the most common malignant tumors with obvious regional distribution differences in incidence and prognosis. There are significant differences in economic development, lifestyle, dietary structure and medical resource allocation between Xinjiang (western China) and Shandong (eastern China), which may lead to different epidemiological characteristics and prognosis of CRC patients in the two regions. This study will enroll CRC patients from 7 multicenters in Xinjiang and Shandong, collect retrospective clinical data including demographic information, pathological features, treatment modes and follow-up records, use statistical methods such as Kaplan-Meier survival analysis and Cox proportional hazard regression model to analyze the 5-year OS rate and prognostic factors of patients in the two regions, compare the regional differences of CRC, and construct a Nomogram prognostic prediction model. The study will provide a scientific basis for the personalized treatment and regional public health prevention and control of CRC.

Interventions

Retrospective collection, collation and statistical analysis of de-identified clinical, pathological, treatment and follow-up data of pathologically confirmed colorectal cancer patients from 7 medical centers in Xinjiang and Shandong provinces from January 1, 2016 to December 31, 2020. The collected data includes demographic characteristics, lifestyle, tumor clinical pathological features, treatment patterns and 5-year overall survival status, for the purpose of analyzing regional epidemiological characteristics and key prognostic factors of colorectal cancer.

Sponsors

Qianfoshan Hospital
Lead SponsorOTHER
The Second Affiliated Hospital of Shandong First Medical University
CollaboratorOTHER
The Affiliated Hospital of Jining Medical University
CollaboratorUNKNOWN
Xinjiang Medical University
CollaboratorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 120 Years
Healthy volunteers
No

Inclusion criteria

* 1\. Pathologically confirmed colorectal adenocarcinoma. 2\. Patients diagnosed between January 1, 2016 and December 31, 2020. 3\. Age ≥ 18 years old. 4\. Complete clinical, pathological, treatment and follow-up data available. 5\. Patients from medical centers in Xinjiang and Shandong regions.

Exclusion criteria

* 1\. Other pathological types of malignant tumors except colorectal adenocarcinoma. 2\. Patients with incomplete clinical data or lost to follow-up. 3\. Patients with severe organ dysfunction or other malignant tumors that may affect survival. 4\. Age \< 18 years old.

Design outcomes

Primary

MeasureTime frameDescription
5-year Overall Survival5 yearsFive-year overall survival rate of patients with colorectal cancer, defined as the time from pathological diagnosis to death from any cause or last follow-up.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026